Generalized Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Generalized Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-03-10Clinical Trial Update: Psychodynamic Internet Treatment Versus Cognitive Behavioral Therapy (CBT) for Generalized Anxiety Disorder [NA]
This is a completed clinical trial comparing psychodynamic internet treatment with cognitive behavioral therapy for Generalized Anxiety Diso…
-
CLINICAL_TRIALS trial_result · 2011-01-31Clinical Trial Update: Study Of Generalized Anxiety Disorder [Phase 2]
This document reports a completed Phase 2 clinical trial sponsored by GlaxoSmithKline evaluating an investigational compound for generalized…
-
CLINICAL_TRIALS trial_result · 2011-01-27Clinical Trial Update: The Comparative Clinical Study of Gamisoyosan on Anxiety of Generalized Anxiety Disorder According to Dosage Form [Phase 3]
Phase 3 clinical trial evaluating Gamisoyosan for generalized anxiety disorder has completed, comparing different dosage forms.
-
CLINICAL_TRIALS trial_result · 2010-12-17Clinical Trial Update: Duloxetine for the Treatment of Generalized Anxiety Disorder [Phase 3]
Phase 3 trial results for duloxetine in generalized anxiety disorder have been completed and results posted.
-
CLINICAL_TRIALS trial_result · 2010-10-08Clinical Trial Update: Proof of Concept in Patients With Generalized Anxiety Disorder (GAD)AZD7325 [Phase 2]
This update reports Phase 2 proof-of-concept results for AZD7325 in patients with generalized anxiety disorder.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-09-29Clinical Trial Update: Exercise Training for the Treatment of Generalized Anxiety Disorder [NA]
A completed clinical trial evaluated exercise training as a treatment for Generalized anxiety disorder, with results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-06-30Clinical Trial Update: ERP N1 as a Treatment Predictor of Generalized Anxiety Disorder [NA]
A completed clinical trial evaluating ERP N1 as a predictor of treatment response in Generalized Anxiety Disorder. The study was sponsored b…
-
CLINICAL_TRIALS trial_result · 2010-05-20Clinical Trial Update: Efficacy, Safety and Tolerability of XBD173 in Patients With Generalized Anxiety Disorder [Phase 2]
Phase 2 trial assessing the efficacy, safety, and tolerability of XBD173 in patients with generalized anxiety disorder. The study status is …
-
CLINICAL_TRIALS trial_result · 2010-03-02Clinical Trial Update: Black Cohosh as Alternative Therapy for Treating Menopause-Related Anxiety [Phase 4]
This update reports the completion of a Phase 4 clinical trial evaluating black cohosh as an alternative therapy for menopause-related anxie…
-
CLINICAL_TRIALS trial_result · 2010-02-19Clinical Trial Update: A 5-Week Trial Of PD 0332334 And Alprazolam Extended Release Compared To Placebo In Patients With Generalized Anxiety Disorder [Phase 2]
A completed Phase 2 randomized trial evaluated PD 0332334 in combination with extended-release alprazolam versus placebo in Generalized Anxi…
-
CLINICAL_TRIALS trial_result · 2010-02-17Clinical Trial Update: Evaluating The Effects Of Cimetidine On The Elimination Of PD 0332334 From The Body [Phase 1]
Phase 1 pharmacokinetic study evaluating whether cimetidine affects the elimination of Pfizer's PD-0332334; the trial was terminated.
-
CLINICAL_TRIALS trial_result · 2010-02-17Clinical Trial Update: Investigation Of How PD 0332334 And Metformin Are Eliminated From The Body When They Are Administered At The Same Time [Phase 1]
Phase 1 pharmacokinetic study evaluating how PD 0332334 and metformin are eliminated when administered together, sponsored by Pfizer; the tr…
-
CLINICAL_TRIALS trial_result · 2009-12-02Clinical Trial Update: Pregabalin in the Treatment of Patients With Generalized Anxiety Disorder (GAD). [Phase 3]
Phase 3 clinical trial update for pregabalin in generalized anxiety disorder has completed with results posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-12-02Clinical Trial Update: Chamomile Therapy for Generalized Anxiety [Phase 4]
Phase 4 study of chamomile therapy for Generalized Anxiety Disorder has completed.
-
CLINICAL_TRIALS trial_result · 2009-11-09Clinical Trial Update: Efficacy and Safety of Pregabalin vs Placebo for Generalized Anxiety Disorder (GAD) Symptoms in Subjects Discontinuing Benzodiazepine Treatment and Remaining 6 Weeks on Study Medication, Free From Benzodiazepine Use. [Phase 3]
Phase 3 trial assessing efficacy and safety of pregabalin versus placebo for generalized anxiety disorder in subjects discontinuing benzodia…
-
CLINICAL_TRIALS trial_result · 2009-10-02Clinical Trial Update: Trial to Compare Time to Response in the Symptoms of Anxiety to Concomitant Treatment With Niravam™ and an SSRI or SNRI to Treatment With an SSRI or SNRI Alone in Subjects With Generalized Anxiety Disorder or Panic Disorder [Phase 4]
A Phase 4 trial compared adding Niravam (alprazolam) to an SSRI or SNRI versus SSRI or SNRI alone in generalized anxiety disorder or panic d…
-
CLINICAL_TRIALS trial_result · 2009-08-10Clinical Trial Update: Aripiprazole for the Treatment of Refractory Anxiety [Phase 4]
Phase 4 clinical trial update evaluating aripiprazole for treatment-refractory anxiety, including generalized anxiety disorder and panic dis…
-
CLINICAL_TRIALS trial_result · 2009-06-23Clinical Trial Update: Efficacy and Safety Study of Seroquel SR in the Treatment of Generalised Anxiety Disorder [Phase 3]
A Phase 3 efficacy and safety study of Seroquel SR for generalized anxiety disorder has completed. Results were posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Safety and Efficacy Maintenance Study of Quetiapine SR to Treat GAD Patients. [Phase 3]
A Phase 3 maintenance trial evaluated the safety and efficacy of quetiapine sustained-release for generalized anxiety disorder and has compl…
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety Disorder [Phase 3]
Phase 3 trial evaluating quetiapine fumarate (SEROQUEL) versus placebo in generalized anxiety disorder has completed, assessing safety and e…
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo & Active Control in Generalized Anxiety Disorder [Phase 3]
This Phase 3 study evaluated the safety and efficacy of quetiapine fumarate (SEROQUEL) versus placebo and an active control in generalized a…
-
CLINICAL_TRIALS trial_result · 2009-03-12Clinical Trial Update: Efficacy and Safety of SR58611A in Patients With a Generalized Anxiety Disorder [Phase 3]
Phase 3 trial evaluating efficacy and safety of SR58611A in generalized anxiety disorder has completed.
-
CLINICAL_TRIALS trial_result · 2009-03-12Clinical Trial Update: An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Patients With Generalized Anxiety Disorder [Phase 3]
Phase 3 study evaluating SR58611A for Generalized anxiety disorder has completed an eight-week efficacy and safety evaluation.
-
CLINICAL_TRIALS trial_result · 2009-03-12Clinical Trial Update: An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Elderly Patients With Generalized Anxiety Disorder [Phase 3]
A Phase 3 study evaluating SR58611A for generalized anxiety disorder in elderly patients has been terminated in an eight-week trial.
-
CLINICAL_TRIALS trial_result · 2009-03-12Clinical Trial Update: Prevention of Relapse Study of SR58611A in Improved Patients With Generalized Anxiety Disorder [Phase 3]
A Phase 3 relapse-prevention study of SR58611A in patients with Generalized Anxiety Disorder has been terminated.